These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8044826)

  • 1. Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma.
    Hill FW; Rutten VP; Hoyer MH; Klein WR; Koten JW; Steerenberg PA; Ruitenberg EJ; Den Otter W
    Cancer Immunol Immunother; 1994 Jul; 39(1):49-52. PubMed ID: 8044826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
    Rutten VP; Klein WR; De Jong WA; Misdorp W; Steerenberg PA; De Jong WH; Den Otter W; Ruitenberg EJ
    Cancer Immunol Immunother; 1991; 34(3):186-90. PubMed ID: 1756535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effect of locally injected low doses of recombinant human interleukin-2 in bovine vulval papilloma and carcinoma.
    Hill FW; Klein WR; Hoyer MJ; Rutten VP; Kock N; Koten JW; Steerenberg PA; Ruitenberg EJ; Den Otter W
    Vet Immunol Immunopathol; 1994 May; 41(1-2):19-29. PubMed ID: 8066994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local interleukin-2 therapy of bovine vulval papilloma and carcinoma complex.
    Stewart RJ; Jacobs JJ; Koten JW; Den Otter W
    Vet Rec; 2010 Nov; 167(21):825-6. PubMed ID: 21262632
    [No Abstract]   [Full Text] [Related]  

  • 5. Attempted immunotherapy and autotransplantation of bovine vulval squamous cell carcinoma.
    Jennings PA; Hoffmann D; Wilson BE
    Aust Vet J; 1979 Dec; 55(12):604-5. PubMed ID: 539949
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of bovine vulval squamous cell carcinoma after immunotherapy.
    Samuel JL
    Aust Vet J; 1989 Jun; 66(6):186-7. PubMed ID: 2775056
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term protection in bladder cancer following intralesional immunotherapy.
    Reichert DF; Lamm DL
    J Urol; 1984 Sep; 132(3):570-3. PubMed ID: 6381762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.
    Klein WR; Ruitenberg EJ; Steerenberg PA; de Jong WH; Kruizinga W; Misdorp W; Bier J; Tiesjema RH; Kreeftenberg JG; Teppema JS; Rapp HJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1095-103. PubMed ID: 6957655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma.
    Misdorp W; Klein WR; Ruitenberg EJ; Hart G; de Jong WH; Steerenberg PA
    Cancer Immunol Immunother; 1985; 20(3):223-30. PubMed ID: 3851702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of bovine papillomavirus type 1 and 2 from bovine anogenital fibropapillomas.
    Yamashita-Kawanishi N; Tsuzuki M; Wei Z; Kok MK; Ishiyama D; Chambers JK; Uchida K; Dong J; Shimakura H; Haga T
    J Vet Med Sci; 2019 Jul; 81(7):1000-1005. PubMed ID: 31155549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus Calmette-Guérin in superficial bladder cancer: consensus and controversies.
    Vegt PD; Debruyne FM; van der Meijden AP
    Eur Urol; 1995; 27(2):89-95. PubMed ID: 7744164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent bladder papillomata treated with bacillus Calmette-Guérin: a preliminary report (phase I trial).
    Douville Y; Pelouze G; Roy R; Charrois R; Kibrité A; Martin M; Dionne L; Coulonval L; Robinson J
    Cancer Treat Rep; 1978 Apr; 62(4):551-2. PubMed ID: 350390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical bacillus Calmette-Guérin therapy for superficial bladder tumors].
    Hirano A; Shinka T; Uekado Y; Komura T; Kyoku I; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1987 Oct; 78(10):1769-75. PubMed ID: 3444170
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoprophylaxis of an ocular solid malignant tumor in cattle.
    Kleinschuster SJ; Rapp HJ; Bier J; Muscoplat CC; Smart RA; Van Kampen KR
    J Natl Cancer Inst; 1983 Apr; 70(4):771-6. PubMed ID: 6572763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential immunocytological evaluation of murine transitional cell carcinoma during intralesional bacillus Calmette-Guerin and interleukin-2 immunotherapy.
    Sosnowski JT; De Haven JI; Abraham FM; Riggs DR; Lamm DL
    J Urol; 1992 May; 147(5):1439-43. PubMed ID: 1569700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerodigestive tract papillomatosis: bacille Calmette-Guérin (BCG) immunotherapy.
    Strauss M; Conner GH; Harvey HA; White DS
    Laryngoscope; 1982 Sep; 92(9 Pt 1):971-5. PubMed ID: 7121166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.
    Kleinschuster SJ; Rapp HJ; Lueker DC; Kainer RA
    J Natl Cancer Inst; 1977 Jun; 58(6):1807-14. PubMed ID: 864757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancer.
    Steinberg GD; Shore ND; Redorta JP; Galsky MD; Bedke J; Ku JH; Kretkowski M; Hu H; Penkov K; Vermette JJ; Tarazi JC; Randall AE; Pierce KJ; Saltzstein D; Powles TB
    Future Oncol; 2024 May; 20(14):891-901. PubMed ID: 38189180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring intravesical bacillus Calmette-Guerin treatment of superficial bladder carcinoma by postoperative urinary cytology.
    Badalament RA; Gay H; Cibas ES; Herr HW; Whitmore WF; Fair WR; Melamed MR
    J Urol; 1987 Oct; 138(4):763-5. PubMed ID: 3656528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.